Reichert F, Slobodov U, Makranz C, Rotshenker S
Department of Anatomy & Cell Biology, Hebrew University-Hadassah Medical School, Jerusalem, 91120, Israel.
Neurobiol Dis. 2001 Jun;8(3):504-12. doi: 10.1006/nbdi.2001.0383.
The removal of damaged myelin is central to repair after injury to axons and in autoimmune demyelinating diseases. Complement receptor 3 (CR3/MAC-1) plays a major role in mediating the phagocytosis of damaged myelin by macrophages and microglia. We studied the modulation (inhibition and augmentation) of CR3/MAC-1 mediated myelin phagocytosis by mAbs that bind to distinct epitopes of subunits alphaM and beta2 of CR3/MAC-1. mAb M1/70 anti-alpha(M) and mAb 5C6 anti-alpha(M) inhibited, whereas mAb M18/2 anti-beta2 augmented myelin phagocytosis. This mAb-induced modulation of myelin phagocytosis occurred in the presence and absence of active complement. Inhibition induced by M1/70 or 5C6 did not add when the two were combined. Combining M1/70 or 5C6 with M18/2 reduced the augmentation induced by M18/2 alone. CR3/MAC-1-mediated myelin phagocytosis may thus be subjected to modulation between efficient and inefficient functional/activation states. These observations and conclusions may offer an explanation for the observed discrepancy between efficient myelin phagocytosis in experimental allergic encephalomyelitis and inefficient myelin phagocytosis after injury to CNS axons, although in both instances macrophages/microglia express CR3/MAC-1.
在轴突损伤后及自身免疫性脱髓鞘疾病中,去除受损髓鞘是修复的核心环节。补体受体3(CR3/MAC-1)在介导巨噬细胞和小胶质细胞对受损髓鞘的吞噬作用中起主要作用。我们研究了与CR3/MAC-1的αM和β2亚基不同表位结合的单克隆抗体对CR3/MAC-1介导的髓鞘吞噬作用的调节(抑制和增强)。抗αM单克隆抗体M1/70和抗αM单克隆抗体5C6抑制髓鞘吞噬作用,而抗β2单克隆抗体M18/2增强髓鞘吞噬作用。这种单克隆抗体诱导的髓鞘吞噬作用调节在有或无活性补体的情况下均会发生。M1/70或5C6单独诱导的抑制作用在两者联合时不会叠加。将M1/70或5C6与M18/2联合使用会降低M18/2单独诱导的增强作用。因此,CR3/MAC-1介导的髓鞘吞噬作用可能在有效和无效的功能/激活状态之间受到调节。这些观察结果和结论可能为实验性变应性脑脊髓炎中髓鞘有效吞噬与中枢神经系统轴突损伤后髓鞘吞噬无效之间观察到的差异提供一种解释,尽管在这两种情况下巨噬细胞/小胶质细胞均表达CR3/MAC-1。